Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 AUD | -12.90% | -35.71% | -38.64% |
Apr. 23 | Zoono Group's Exclusive Agent OSY Signs First Major UK Client; Shares Up 18% | MT |
Mar. 26 | Evolution Capital, OSY Group to Underwrite Zoono Group's AU$2.9 Million Rights Issue | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antimicrobial Products
100.0
%
| 8 | 100.0 % | 3 | 100.0 % | -63.87% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australasia, Asia, United States, India
85.2
%
| 5 | 54.5 % | 3 | 85.2 % | -43.47% |
United Kingdom and Europe
14.8
%
| 4 | 45.5 % | 0 | 14.8 % | -88.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Hyslop
CEO | Chief Executive Officer | - | - |
Paul Ravlich
DFI | Director of Finance/CFO | - | 17-04-30 |
Lew MacKinnon
COO | Chief Operating Officer | - | - |
Elissa Hansen
BRD | Director/Board Member | 51 | 15-10-08 |
Michael Wu
PRN | Corporate Officer/Principal | - | - |
Lloyd Johns
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Clarke
BRD | Director/Board Member | 69 | 17-04-25 |
Elissa Hansen
BRD | Director/Board Member | 51 | 15-10-08 |
Paul Hyslop
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 318,516,091 | 105,957,364 ( 33.27 %) | 0 | 33.27 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-38.64% | 4.38M | |
+12.22% | 388B | |
+10.21% | 132B | |
-15.32% | 62.43B | |
-11.06% | 47.67B | |
-11.38% | 36.76B | |
+6.08% | 34.51B | |
+10.80% | 17.86B | |
+10.52% | 15.35B | |
-4.74% | 11.3B |
- Stock Market
- Equities
- ZNO Stock
- Company Zoono Group Limited